{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://kaziatherapeutics.com/site/content/#organization",
      "name": "Kazia Therapeutics Limited",
      "url": "https://kaziatherapeutics.com/site/content/",
      "description": "Kazia is an Australian oncology company developing innovative, high-impact drugs for cancer. Our lead program is paxalisib, which is being developed to treat glioblastoma, the most common and most aggressive form of primary brain cancer in adults."
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/kazia-therapeutics-limited#asg",
      "name": "Kazia Therapeutics Limited ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/kazia-therapeutics-limited",
      "isPartOf": {
        "@id": "https://kaziatherapeutics.com/site/content/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}